Pharmaceuticals and Medical Devices Agency

From LIMSWiki
Jump to: navigation, search
Pharmaceuticals and Medical Devices Agency
Pharmaceuticals and Medical Devices Agency.svg
Agency overview
FormedApril 1, 2004

The Pharmaceuticals and Medical Devices Agency (独立行政法人医薬品医療機器総合機構, Dokuritsugyōsei hōjin iyakuhin'iryōkikisōgōkikō) is an Independent Administrative Institution responsible for ensuring the safety, efficacy and quality of pharmaceuticals and medical devices[1] in Japan. It is similar in function to the Food and Drug Administration in the United States or the Medicines and Healthcare products Regulatory Agency in the United Kingdom.[2]


Among other things, the agency is tasked with the following:

  • Drug and medical device testing:
  • Post-marketing drug safety:
    • The collection, analysis and distribution of data on the quality, efficacy, and safety data of medicines and medical devices
    • Advising consumers on approved products
    • Research on the development of industry standards
  • Victim compensation:
    • Payment of medical costs, lost wages, and pain and suffering for those who suffer injury or disability resulting from the use of medical products
    • Disbursement of funds to those infected with HIV as a result of blood transfusions


The chief executive of the agency is Yasuhiro Fujiwara, former head of the National Cancer Center Japan. From 2008 to 2018, the chief executive of the agency was Tatsuya Kondo, a neurosurgeon and graduate of the University of Tokyo.


  1. ^ "Japan Medical Device Registration". Qualtech.
  2. ^ Nagasaka, Satoru. "An Overview of Pharmaceutical and Medical Device Regulation in Japan" (PDF). Morgan, Lewis & Bockius LLP. Archived from the original (PDF) on 11 February 2014. Retrieved 30 September 2012.

External links


This article is a direct transclusion of the Wikipedia article and therefore may not meet the same editing standards as LIMSwiki.